PortfoliosLab logoPortfoliosLab logo
USD vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

USD vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Semiconductors (USD) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, USD achieves a 58.94% return, which is significantly higher than CURE's 1.16% return. Over the past 10 years, USD has outperformed CURE with an annualized return of 55.50%, while CURE has yielded a comparatively lower 12.86% annualized return.


USD

1D
1.19%
1M
-23.32%
6M
44.94%
YTD
58.94%
1Y
100.99%
3Y*
97.07%
5Y*
57.89%
10Y*
55.50%
ALL TIME*
28.48%

CURE

1D
-3.42%
1M
20.37%
6M
-0.05%
YTD
1.16%
1Y
55.41%
3Y*
2.89%
5Y*
1.12%
10Y*
12.86%
ALL TIME*
23.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

USD vs. CURE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
USD
ProShares Ultra Semiconductors
58.94%62.08%139.64%228.79%-68.57%104.27%68.16%110.37%-26.88%81.72%
CURE
Direxion Daily Healthcare Bull 3x Shares
1.16%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between USD and CURE is -0.10, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.36

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2011

0.42

The correlation between USD and CURE shifts across timeframes, from -0.10 (1 year) to 0.42 (all time), reflecting how their relationship changes across market environments.

USD vs. CURE - Sectors Allocation Comparison


Sectors
USD
CURE

Technology

30.8%

-

Financial Services

30.0%

-

Energy

0.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Healthcare

-

100.0%

Industrials

-

-

Real Estate

-

-

Utilities

-

-

Technology

USD
30.8%
CURE

-

Financial Services

USD
30.0%
CURE

-

Energy

USD
0.0%
CURE

-

Basic Materials

USD

-

CURE

-

Communication Services

USD

-

CURE

-

Consumer Cyclical

USD

-

CURE

-

Consumer Defensive

USD

-

CURE

-

Healthcare

USD

-

CURE
100.0%

Industrials

USD

-

CURE

-

Real Estate

USD

-

CURE

-

Utilities

USD

-

CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

USD vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

USD
USD Risk / Return Rank: 6161
Overall Rank
USD Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
USD Sortino Ratio Rank: 5151
Sortino Ratio Rank
USD Omega Ratio Rank: 5353
Omega Ratio Rank
USD Calmar Ratio Rank: 8282
Calmar Ratio Rank
USD Martin Ratio Rank: 6262
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 4444
Overall Rank
CURE Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 5151
Sortino Ratio Rank
CURE Omega Ratio Rank: 4343
Omega Ratio Rank
CURE Calmar Ratio Rank: 4646
Calmar Ratio Rank
CURE Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

USD vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Semiconductors (USD) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


USDCUREDifference
Sharpe ratioReturn per unit of total volatility

+0.23

Sortino ratioReturn per unit of downside risk

-0.01

Omega ratioGain probability vs. loss probability

1.25

1.21

+0.04

Calmar ratioReturn relative to maximum drawdown

3.19

1.79

+1.40

Martin ratioReturn relative to average drawdown

8.07

3.98

+4.09

USD vs. CURE - Sharpe Ratio Comparison

The current USD Sharpe Ratio is 1.43, which is comparable to the CURE Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of USD and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

USD vs. CURE - Drawdown Comparison

The maximum USD drawdown since its inception was -88.63%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for USD and CURE.


Loading charts...

Drawdown Indicators


USDCUREDifference

Max Drawdown

Largest peak-to-trough decline

-88.63%

-69.19%

-19.44%

Max Drawdown (1Y)

Largest decline over 1 year

-31.80%

-31.10%

-0.70%

Max Drawdown (3Y)

Largest decline over 3 years

-64.46%

-51.93%

-12.53%

Max Drawdown (5Y)

Largest decline over 5 years

-77.85%

-52.23%

-25.62%

Max Drawdown (10Y)

Largest decline over 10 years

-77.85%

-69.19%

-8.66%

Current Drawdown

Current decline from peak

-26.57%

-19.70%

-6.87%

Average Drawdown

Average peak-to-trough decline

-32.24%

-18.17%

-14.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.55%

13.96%

-1.41%

Volatility

USD vs. CURE - Volatility Comparison

ProShares Ultra Semiconductors (USD) has a higher volatility of 29.84% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 18.53%. This indicates that USD's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


USDCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.84%

18.53%

+11.31%

Volatility (6M)

Calculated over the trailing 6-month period

58.46%

34.70%

+23.76%

Volatility (1Y)

Calculated over the trailing 1-year period

71.29%

46.73%

+24.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.30%

44.52%

+33.78%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

70.12%

49.77%

+20.35%

USD vs. CURE - Expense Ratio Comparison

USD has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.


Dividends

USD vs. CURE - Dividend Comparison

USD's dividend yield for the trailing twelve months is around 0.36%, less than CURE's 1.12% yield.


PositionTTM20252024202320222021202020192018201720162015
CURE
Direxion Daily Healthcare Bull 3x Shares
1.12%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%
USD
ProShares Ultra Semiconductors
0.36%0.39%0.10%0.05%0.30%0.00%0.14%0.72%0.93%0.32%0.46%0.39%

Frequently Asked Questions


USD and CURE have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

USD has higher volatility (29.84%) compared to CURE (18.53%). In terms of maximum drawdown, USD dropped -88.63% vs CURE's -69.19%.

On 10-year performance, USD leads with 55.50% vs 12.86% for CURE. On fees, USD is cheaper at 0.95% per year. On volatility, CURE has been the lower-risk option at 18.53%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, USD has performed better with a 55.50% return vs 12.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

USD is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.12%, compared with 0.36% for USD.

USD tracks Dow Jones U.S. Semiconductors Index (200%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for USD and 1.08% for CURE.

USD currently has the higher Sharpe Ratio (1.43 vs 1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for USD and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer